XML 13 R42.htm IDEA: XBRL DOCUMENT
v3.20.1

Stockholders' Equity (Deficit) and Capitalization (Detail Textuals) - USD ($) | 1 Months Ended | 12 Months Ended |
--- | --- | --- | ---
Dec. 20, 2019 | Nov. 30, 2019 | Feb. 16, 2018 | Jan. 19, 2018 | Dec. 31, 2019 | Dec. 31, 2018 | Nov. 15, 2018
Equity [Line Items] |  |  |  |  |  |  |
Common stock, shares authorized |  |  |  |  | 500,000,000 | 500,000,000 | 500,000,000
Common stock gross proceeds |  |  |  |  | $ 1,919,372 | $ 3,095,908 |
Warrant liability, issuance costs |  |  |  |  |  | 137,192 |
2018 Emerald Financing Warrants |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Warrants exercise | 40,800,000 |  |  |  | 40,800,000 |  |
Intrinsic value of warrant exercises |  |  |  |  | $ 4,284,000 |  |
Number of warrants issued |  |  |  |  | 40,800,000 |  |
Warrant exercise price |  |  |  |  | $ 0.10 |  |
Series B Warrants |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Intrinsic value of warrant exercises |  |  |  |  |  | $ 144,375 |
Number of warrants issued |  |  |  |  |  | 187,500 |
Direct offering |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Number of stock sold |  | 8,000,000 |  |  |  |  |
Common stock, par value (per share) |  | $ 0.001 |  |  |  |  |
Net proceeds from the transaction |  | $ 1,919,372 |  |  |  |  |
Number of warrants issued |  | 8,000,000 |  |  |  |  |
Private placement |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Emerald financing issuance costs |  |  |  |  | $ 154,092 |  |
Warrant liability, issuance costs |  |  |  |  | 137,192 |  |
Reduction to APIC from the issuance of common stock |  |  |  |  | $ 16,900 |  |
Securities Purchase Agreement | Emerald Health Sciences Inc |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Common stock issued |  |  | 15,000,000 | 15,000,000 |  |  |
Number of warrants issued |  |  | 20,400,000 | 20,400,000 |  |  |
Warrant exercise price |  |  | $ 0.10 | $ 0.10 |  |  |
Common stock gross proceeds |  |  |  | $ 1,500,000 |  |  |
Subsequent financing purchase price, description |  |  |  | The Securities Purchase Agreement also provides that in the case of a subsequent financing in which the purchase price is less than $0.10 per share, Emerald Health Sciences shall be issued additional shares in order to protect against anti-dilution. |  |  |
Term of warrants |  |  | 5 years |  |  |  |
Securities Purchase Agreement | Emerald Health Sciences Inc | Accredited Investor |  |  |  |  |  |  |
Equity [Line Items] |  |  |  |  |  |  |
Common stock issued |  |  | 2,500,000 |  |  |  |
Number of warrants issued |  |  | 3,400,000 |  |  |  |
Warrant exercise price |  |  | $ 0.10 |  |  |  |
Common stock gross proceeds |  |  | $ 1,750,000 |  |  |  |
Term of warrants |  |  | 5 years |  |  |  |

X
- Definition Represents number of warrants exercise. + References No definition available. + Details
Name: | embi_ClassOfWarrantOrRightWarrantsExercise
Namespace Prefix: | embi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cost incurred for Emerald Financing, issuance. + References No definition available. + Details
Name: | embi_EmeraldFinancingIssuanceCosts
Namespace Prefix: | embi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | embi_EquityLineItems
Namespace Prefix: | embi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents intrinsic value of warrant exercises. + References No definition available. + Details
Name: | embi_IntrinsicValueOfWarrantExercises
Namespace Prefix: | embi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of reduction to APIC from the issuance of common stock. + References No definition available. + Details
Name: | embi_ReductionToAdditionalPaidInCapitalFromTheIssuanceOfCommonStock
Namespace Prefix: | embi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents subsequent financing purchase price description to protect against anti-dilution. + References No definition available. + Details
Name: | embi_SubsequentFinancingPurchasePriceDescription
Namespace Prefix: | embi_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents term of warrants. + References No definition available. + Details
Name: | embi_TermOfWarrants
Namespace Prefix: | embi_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for cost incurred directly with the issuance of a derivative security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfDerivativeIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=embi_TwoThousandEighteenEmeraldFinancingWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=embi_SeriesBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=embi_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=embi_EmeraldHealthSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |